alpha-hydroxyglutarate has been researched along with Bile Duct Cancer in 6 studies
2-hydroxyglutarate : A dicarboxylic acid anion obtained by deprotonation of at least one of the carboxy groups of 2-hydroxyglutaric acid.
2-hydroxyglutaric acid : A 2-hydroxydicarboxylic acid that is glutaric acid in which one hydrogen alpha- to a carboxylic acid group is substituted by a hydroxy group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, Q | 3 |
| Delahousse, J | 1 |
| Verlingue, L | 1 |
| Broutin, S | 1 |
| Legoupil, C | 1 |
| Touat, M | 1 |
| Doucet, L | 1 |
| Ammari, S | 1 |
| Lacroix, L | 1 |
| Ducreux, M | 1 |
| Scoazec, JY | 1 |
| Malka, D | 1 |
| Paci, A | 1 |
| Hollebecque, A | 1 |
| Guilhamon, P | 1 |
| Eskandarpour, M | 1 |
| Halai, D | 1 |
| Wilson, GA | 1 |
| Feber, A | 1 |
| Teschendorff, AE | 1 |
| Gomez, V | 1 |
| Hergovich, A | 1 |
| Tirabosco, R | 1 |
| Fernanda Amary, M | 1 |
| Baumhoer, D | 1 |
| Jundt, G | 1 |
| Ross, MT | 1 |
| Flanagan, AM | 1 |
| Beck, S | 1 |
| Borger, DR | 1 |
| Goyal, L | 1 |
| Yau, T | 1 |
| Poon, RT | 1 |
| Ancukiewicz, M | 1 |
| Deshpande, V | 2 |
| Christiani, DC | 1 |
| Liebman, HM | 1 |
| Yang, H | 1 |
| Kim, H | 1 |
| Yen, K | 1 |
| Faris, JE | 1 |
| Iafrate, AJ | 1 |
| Kwak, EL | 1 |
| Clark, JW | 1 |
| Allen, JN | 1 |
| Blaszkowsky, LS | 1 |
| Murphy, JE | 1 |
| Saha, SK | 2 |
| Hong, TS | 1 |
| Wo, JY | 1 |
| Ferrone, CR | 2 |
| Tanabe, KK | 1 |
| Bardeesy, N | 2 |
| Straley, KS | 2 |
| Agresta, S | 1 |
| Schenkein, DP | 1 |
| Ellisen, LW | 1 |
| Ryan, DP | 1 |
| Zhu, AX | 2 |
| Grassian, AR | 1 |
| Pagliarini, R | 1 |
| Chiang, DY | 1 |
| Parachoniak, CA | 1 |
| Ghanta, KS | 1 |
| Fitamant, J | 1 |
| Ross, KN | 1 |
| Najem, MS | 1 |
| Gurumurthy, S | 1 |
| Akbay, EA | 1 |
| Sia, D | 1 |
| Cornella, H | 1 |
| Miltiadous, O | 1 |
| Walesky, C | 1 |
| Hezel, AF | 1 |
| Yen, KE | 1 |
| Travins, J | 1 |
| Popovici-Muller, J | 1 |
| Gliser, C | 1 |
| Apte, U | 1 |
| Llovet, JM | 1 |
| Wong, KK | 1 |
| Ramaswamy, S | 1 |
2 reviews available for alpha-hydroxyglutarate and Bile Duct Cancer
| Article | Year |
|---|---|
Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2.
Topics: Bile Duct Neoplasms; Bone Neoplasms; Central Nervous System Neoplasms; Cholangiocarcinoma; Chondrosa | 2013 |
Mutations of isocitrate dehydrogenase 1 and 2 in intrahepatic cholangiocarcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Differentiation; Cholangiocarcinoma; DNA Methyla | 2014 |
4 other studies available for alpha-hydroxyglutarate and Bile Duct Cancer
| Article | Year |
|---|---|
Mutant IDH1 attenuates hepatic lipogenesis through PTEN dependent pathway.
Topics: Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Lipogenesis; Liver; Mice; Mutant Proteins | 2022 |
Mutant IDH1 attenuates hepatic lipogenesis through PTEN dependent pathway.
Topics: Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Lipogenesis; Liver; Mice; Mutant Proteins | 2022 |
Mutant IDH1 attenuates hepatic lipogenesis through PTEN dependent pathway.
Topics: Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Lipogenesis; Liver; Mice; Mutant Proteins | 2022 |
Mutant IDH1 attenuates hepatic lipogenesis through PTEN dependent pathway.
Topics: Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Lipogenesis; Liver; Mice; Mutant Proteins | 2022 |
Mutant IDH1 attenuates hepatic lipogenesis through PTEN dependent pathway.
Topics: Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Lipogenesis; Liver; Mice; Mutant Proteins | 2022 |
Mutant IDH1 attenuates hepatic lipogenesis through PTEN dependent pathway.
Topics: Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Lipogenesis; Liver; Mice; Mutant Proteins | 2022 |
Mutant IDH1 attenuates hepatic lipogenesis through PTEN dependent pathway.
Topics: Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Lipogenesis; Liver; Mice; Mutant Proteins | 2022 |
Mutant IDH1 attenuates hepatic lipogenesis through PTEN dependent pathway.
Topics: Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Lipogenesis; Liver; Mice; Mutant Proteins | 2022 |
Mutant IDH1 attenuates hepatic lipogenesis through PTEN dependent pathway.
Topics: Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Lipogenesis; Liver; Mice; Mutant Proteins | 2022 |
Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase-mutated intrahepatic cholangiocarcinomas.
Topics: Adult; Aged; Bile Duct Neoplasms; Biomarkers, Tumor; Cholangiocarcinoma; Female; Glutarates; Humans; | 2018 |
Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma.
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers, Tumor; Cholangiocarcinoma; F | 2014 |
Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer.
Topics: Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Differentiation; Cell Division; Cell Li | 2014 |